grant

Metabolic changes that promote adaptation of Listeria monocytogenes to oxidative stress and preserving intracellular redox homeostasis

Organization MISSISSIPPI STATE UNIVERSITYLocation MISSISSIPPI STATE, UNITED STATESPosted 6 Dec 2023Deadline 30 Nov 2026
NIHUS FederalResearch GrantFY2024Active OxygenAffectAminobenzyl PenicillinAminobenzylpenicillinAmpicillinAnimalsAntibiotic TherapyAntibiotic TreatmentAntioxidantsAttenuatedAutoregulationBacteriaBand Shift Mobility AssayBandshift Mobility AssayCarbonCell BodyCellsCoenzyme IID-GlucoseD-RiboseDNA Damage RepairDNA RepairDeath RateDevelopmentDextroseDrug Metabolic DetoxicationDrug Metabolic DetoxificationE coliE. coliElectrophoretic Mobility Shift AssayEnvironmentEnzyme GeneEnzymesEquilibriumEscherichia coliEukaryotic CellExposure toFamilyFutureGene ExpressionGene TranscriptionGenesGenetic TranscriptionGlucoseGlutathioneGlycolysisGoalsGreen Fluorescent ProteinsHexose Monophosphate ShuntHomeostasisHost DefenseHost Defense MechanismHumanInfectionIntermediary MetabolismKnowledgeL monocytogenesL. monocytogenesLabelListeria InfectionsListeria monocytogenesListeriosisMammalian CellMediatingMetabolicMetabolic Drug DetoxicationsMetabolic PathwayMetabolic ProcessesMetabolismMetabolism of Toxic AgentsMiceMice MammalsMobility Shift AssayModern ManMurineMusNAD phosphateNAD(H) phosphateNADH phosphateNADPNADPHNicotinamide-Adenine Dinucleotide PhosphateNutrientOxidation-ReductionOxidative BurstOxidative StressOxidative Stress InductionOxygen RadicalsPathogenesisPathogenicityPathway interactionsPenicillinsPentose Phosphate PathwayPentose Phosphate ShuntPentose ShuntPentosephosphate PathwayPentosephosphate ShuntPhagocytesPhagocytic CellPhagosomesPhosphatesPhysiological HomeostasisPro-OxidantsProductionProteinsRNA ExpressionRNA SeqRNA sequencingRNAseqReactive Oxygen SpeciesRedoxRegulationReporterReportingResistanceRespiratory BurstRiboseRoleRouteStressSystemSystemic infectionTRX geneTRX proteinTRX1TXN geneTestingTherapeutic AgentsThioredoxinToxic effectToxicitiesTranscriptionTriphosphopyridine NucleotideUnscheduled DNA SynthesisUp-RegulationUpregulationVirulenceYeastsamebocyteanti-oxidant enzymeantioxidant enzymeattenuateattenuatesbacterial disease treatmentbacterial infectious disease treatmentbalancebalance functionbiological adaptation to stresscombatdetoxificationdevelopmentalenzyme pathwayfood-born infectionfood-borne infectionfoodborn infectionfoodborne infectionfoodborne infectious diseasegamma-L-Glu-L-Cys-Glygamma-L-Glutamyl-L-Cysteinylglycinegel shift assayglutaredoxinhuman pathogeninnovateinnovationinnovativeinorganic phosphateleukocyte oxidative burstmetabolism measurementmetabolomicsmetabonomicsmortality ratemortality rationew drug treatmentsnew drugsnew pharmacological therapeuticnew therapeuticsnew therapynext generation therapeuticsnovelnovel drug treatmentsnovel drugsnovel pharmaco-therapeuticnovel pharmacological therapeuticnovel therapeuticsnovel therapyoxidation reduction reactionoxidative damageoxidative injurypathogenpathwayperoxiredoxinpreservationpromoterpromotorreaction; crisisresistantresponsesocial rolestress responsestress; reactiontranscriptome sequencingtranscriptomic sequencing
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Full Description

Project Summary
Listeria monocytogenes (LM) is the causative agent of listeriosis, a fatal foodborne infection in humans and

animals. Invasive form of listeriosis has a mortality rate that ranges from approximately 20%-30% or higher

despite antibiotic treatment. Penicillin or ampicillin are reportedly bacteriostatic for LM infections and require

effective host defense mechanisms for bacterial clearance. New effective strategies for successful treatment of

LM invasive infections are urgently needed. The ability of LM to counteract oxidative stress and reactive

oxygen species (ROS) is essential for survival in phagocytic cells and established infection. However, less is

known regarding how LM manages or detoxifies ROS encountered during systemic infection. The goal of this

proposal is to understand how LM adapts its metabolism and metabolic pathways to alleviate deleterious

effects of oxidative stress and adapt to the host environment. The working hypothesis of this application is

that FruR alters LM metabolism by shifting metabolic flux from glycolysis to PPP, this metabolic switch is

critical for LM’s ability to counteract oxidative stress. This hypothesis will be tested with the following three

specific aims: (Aim 1) Explore whether FruR regulates an LM shift from glycolysis to the PPP to combat

oxidative stress. In this aim, we will use metabolomics analysis to identify glycolysis and PPP metabolites

impacted by FruR upon exposure to oxidative stress. We will also determine the role of FruR in rerouting flux

from glycolysis to PPP using 13C-perturbation. (Aim 2) Determine the role of FruR in generating NADPH and

protecting against host oxidative burst. In this aim, we will verify if the ΔfruR strain could be complemented by

expression of NADPH enzymes. We will investigate the contribution of FruR to LM resistance against ROS

produced by the host respiratory burst. (Aim 3) Decipher the role of the oxidative branch of PPP in resistance

of LM to oxidative stress via regulation of redox status. In this aim, we will determine the role of two NADPH-

producing enzymes in maintaining intracellular redox balance using redox-sensitive green fluorescent protein

(GFP) reporter, roGFP2. This study is innovative because it will test a novel mechanism by which LM

responds to oxidative stress and host respiratory burst. This mechanism involves upregulation of PPP,

focusing on metabolic regulation as a mechanism of LM pathogenesis is a highly innovative approach and

could be widespread among other human pathogens. The proposed project is significant because it will (a)

delineate the role of FruR on protecting LM from oxidative stress and innate host defenses, (b) provide an

opportunity to investigate a new connection between metabolism and virulence, (c) provide a set of metabolic

proteins that could be targeted to develop novel therapeutic agents, and (b) enhance understanding of survival

mechanisms and oxidative stress response of other intracellular pathogens.

Grant Number: 1R15AI180880-01
NIH Institute/Center: NIH

Principal Investigator: Hossam Abdelhamed

Sign up free to get the apply link, save to pipeline, and set email alerts.

Sign up free →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →